Presentation Information
[PE-046]Thromboembolic Risk of Upadacitinib in Inflammatory Bowel Disease: A Real-World Pharmacovigilance Analysis of Timing, Subtypes, and High-Risk Populations
*Chen Pan1, Siying Zhu2, Ying Zhao1, Xiangli Cui1, Ye Zong2 (1. Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing , China, 2. Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing, China)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.
Comment
To browse or post comments, you must log in.Log in